Adage Capital Management, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol
ALGS
Shares outstanding
5,384,615 shares
Disclosed Ownership
210,000 shares
Ownership
3.9%
Form type
SCHEDULE 13G/A
Filing time
12 Aug 2025, 09:00:35 UTC
Date of event
30 Jun 2025
Previous filing
12 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Adage Capital Management, L.P. disclosed 3.9% ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS) on 30 Jun 2025."

Quick Takeaways

  • Adage Capital Management, L.P. filed SCHEDULE 13G/A for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS).
  • Disclosed ownership: 3.9%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 12 Feb 2025.
  • Current filing was accepted on 12 Aug 2025, 09:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 3.9% 210,000 0 210,000 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 3.9% 210,000 0 210,000 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 3.9% 210,000 0 210,000 /s/ Phillip Gross Phillip Gross, individually

Sponsored